Bayer
Prezzo: 10.44Società e modello di business
Bayer AG is a global healthcare and life sciences company that operates in pharmaceuticals, consumer health, crop science, and animal health. Its core products include prescription medications, over-the-counter products, agricultural solutions, and veterinary products. Major business segments are Pharmaceuticals, Consumer Health, Crop Science, and Animal Health, with revenue primarily derived from pharmaceutical sales and crop protection products.
Profilo di investimento
The investment profile of Bayer is more aligned with value investors due to its current low stock price relative to earnings and modest dividend yield. The company faces significant risks, which may deter growth-focused investors. The stock may appeal to those seeking stability and potential recovery over time rather than immediate gains.
Metriche fondamentali (sperimentale)
- EPS (TTM) — utile per azione degli ultimi 12 mesi, $
- -0.53 Rischio
- Ricavi QoQ — crescita dei ricavi trimestre su trimestre
- 20.3% ↑
- Sorpresa EPS
- 23.4% meglio del previsto
- Volatilità 20g
- 1.8% stabile
- Rendimento dividendo
- 0.3% basso ultima data ex-dividendo: 2026-04-28
Traccia in portafoglio
Grafico prezzo
| Data | Prima | Dopo | Motivo |
|---|---|---|---|
| 2026-05-30 02:31 | Mantieni | Vendi | Weak fundamentals and negative momentum raise significant concerns. |
| 2026-05-22 02:37 | Vendi | Mantieni | Weak fundamentals and mixed momentum signal caution. |
| 2026-05-08 15:33 | — | Vendi | Weak fundamentals and negative momentum signal high risk. |
Ancora nulla